Malaysia inks pact with Pfizer to vaccinate 6.4 million citizens
[KUALA LUMPUR] Malaysia signed an agreement with Pfizer to obtain its Covid-19 vaccine for 20 per cent of the population, or about 6.4 million people, according to the nation's Science, Technology and Innovation Minister Khairy Jamaluddin.
The Malaysian National Pharmaceutical Regulatory Agency will evaluate the vaccine for its safety and efficacy before it is administered to the people starting next year, the minister said in a Facebook post.
Pfizer earlier this month announced its vaccine was 95 per cent effective at preventing the disease after undergoing a third phase clinical trial on 43,998 people worldwide, including children and the elderly, Mr Khairy said.
Pfizer will deliver one million doses in the first quarter of 2021, followed 1.7 million in the second, 5.8 million in the third and 4.3 million in the final three months of the year, Malaysiakini reported earlier Friday, citing Prime Minister Muhyiddin Yassin at a press conference.
Malaysia also signed an accord with the Covax facility to provide vaccines for 10 per cent of the population.The two agreements are expected to guarantee access to Covid vaccines for 30 per cent of the citizens reported Malaysiakini.
Vaccines will be available to locals for free, while foreigners residing in Malaysia will have to pay for them. A detailed vaccine roll-out plan will be announced in January.
A NEWSLETTER FOR YOU
Asean Business
Business insights centering on South-east Asia's fast-growing economies.
Malaysia will conduct its first Covid-19 vaccine trial in December as part of a government-to-government agreement with China, Kini reported separately, citing Mr Muhyiddin. It will be a phase-III trial on a vaccine candidate developed by the Institute of Medical Biology Chinese Academy of Medical Sciences. Trial will involve 3,000 participants and will assess the safety and efficacy of the vaccine in development.
BLOOMBERG
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
International
S&P downgrades Israel rating on heightened geopolitical risk
‘We have our jury’: panel selected for Trump criminal trial
UK wage growth and services inflation too high for rate cut, BOE’s Greene says
US to reduce licensing by 80% for UK, Australia to boost Aukus
IMF tells Asian central banks not to follow Fed too closely
UN chief warns Mideast on brink of 'full-scale regional conflict'